Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives
Clinical Pharmacology: Advances and Applications · 2016
DOI: 10.2147/cpaa.s100759 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Pharmacology: Advances and Applications, 2016. Verfasst von Béla Z Schmidt und 3 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell Biology and Embryology, Department of Development and Regeneration, Katholieke Universiteit Leuven, Leuven. Die Arbeit wurde bisher 27-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Stem Cell Biology and Embryology, Department of Development and Regeneration, Katholieke Universiteit Leuven, Leuven.
- Louvain Center for Toxicology and Applied Pharmacology, Université Catholique de Louvain, Brussels, Belgium.
Zitieren
APA
Schmidt, B. Z., Haaf, J. B., Leal, T., & Noel, S. (2016). Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives. Clinical Pharmacology: Advances and Applications. https://doi.org/10.2147/cpaa.s100759
Vancouver
Schmidt BZ, Haaf JB, Leal T, Noel S. Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives. Clinical Pharmacology: Advances and Applications. 2016. doi:10.2147/cpaa.s100759
BibTeX
@article{Schmidt2016,
author = {Schmidt, Béla Z and Haaf, Jérémy B and Leal, Teresinha and Noel, Sabrina},
title = {Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives},
journal = {Clinical Pharmacology: Advances and Applications},
year = {2016},
doi = {10.2147/cpaa.s100759}
}
EUVIMED